-
公开(公告)号:US11534547B2
公开(公告)日:2022-12-27
申请号:US16725069
申请日:2019-12-23
Applicant: AMGEN INC.
Inventor: Daniel Eduardo Groszmann , Scott Robert Gibson
Abstract: Systems and methods for drug delivery with pressure sensitive control are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, a drug delivery device coupled to the reservoir to deliver the drug from the reservoir to a patient, a pressure sensor, an output device, and a controller. The controller may be configured to determine if the drug delivery device has completed delivering a dose of the drug to the patient, and if delivery of the dose of the drug is complete, to measure tissue back pressure using the pressure sensor. Subsequently, the controller may be configured to determine if the tissue back pressure is below a first predetermined value, and if so, control the output device at least once and/or control a mechanism to retract an administration member from the patient.
-
公开(公告)号:US20220355025A1
公开(公告)日:2022-11-10
申请号:US17641458
申请日:2020-10-05
Applicant: AMGEN INC.
Inventor: Tohid Pirbodaghi , Samin Akbari , Joshua Tamsky , Paul Daniel Faucher , Scott Robert Gibson , Sheldon B. Moberg
Abstract: A drug delivery device includes a housing, a container disposed in the housing, an activation mechanism, and a needle insertion mechanism (NIM). The container has an inner volume to contain a medicament which is urged out of the container by the activation mechanism. The needle insertion mechanism (NIM) is operably coupled with the activation mechanism and includes an actuation assembly adapted to insert a needle and a cannula to deliver the medicament from the container. The actuation assembly is movable between a storage state, a first operational state, a second operational state, and a third operational state to selectively position the needle and the cannula.
-
公开(公告)号:US11154661B2
公开(公告)日:2021-10-26
申请号:US16060555
申请日:2017-01-04
Applicant: AMGEN INC.
Inventor: Scott Robert Gibson , Donald Busby , Adam B. McCullough , Peter V. Shultz , Jimmie L. Ward , Huaying Yang , Desheng Yin , Steven William Badelt , Christopher R. Folk , Keith P. Kogler , Mark Ka Lai Lee , Ferry Tamtoro
Abstract: A drug delivery device includes a housing defining a shell comprising a front portion and a rear portion slidably coupled to the front portion, a drug delivery assembly at least partially disposed within the housing, at least one electronic component, a power source which powers the electronic component, and a switch assembly. The switch assembly is adapted to selectively cause the power source to provide power to the at least one electronic component.
-
公开(公告)号:US12208238B2
公开(公告)日:2025-01-28
申请号:US17360140
申请日:2021-06-28
Applicant: AMGEN INC.
Inventor: Scott Robert Gibson , Sudeshna Dutta Ray , Daniel Eduardo Groszmann , Mehran Mojarrad , Nathan Thomas Balcom , Alejandro Campillo-Agusti , Alan D. Payne , Lawrence Scott Ring
Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.
-
公开(公告)号:US12042642B2
公开(公告)日:2024-07-23
申请号:US17264157
申请日:2019-09-17
Applicant: AMGEN INC.
Inventor: Sudeshna Dutta Ray , Scott Robert Gibson , Daniel Eduardo Groszmann , Mehran Mojarrad , Andrew James Carlson , Lee Gordon Macklem , Mikhail Tikh
CPC classification number: A61M5/31576 , A61M5/14248 , A61M5/1452 , A61M2005/1585 , A61M2005/31588 , A61M2205/52
Abstract: Drug delivery devices are described that include an escapement activation assembly. The escapement activation assembly includes a slide having a plurality of pallet engagement portions and a switch engagement portion and a pallet having a plurality of slide engagement portions. A drive is coupled to the pallet to cause the pallet to move relative to the slide to move the plurality of slide engagement portions into and out of engagement with the plurality of pallet engagement portions to allow the slide to move along a path within the drug delivery device. Movement of the slide can cause the switch engagement portion to move out of engagement with an activation trigger of a mechanism of the drug delivery device.
-
公开(公告)号:US12029882B2
公开(公告)日:2024-07-09
申请号:US16905960
申请日:2020-06-19
Applicant: AMGEN INC.
Inventor: Christopher R. Folk , Scott Robert Gibson
CPC classification number: A61M5/3134 , A61M5/20 , A61M5/2033 , A61M5/31511 , F16F9/16 , F16F9/3228 , F16F9/3481 , F16F9/361 , A61M2005/2086 , A61M2005/3143 , A61M5/3243
Abstract: An injection device, method, and system for drug delivery includes a primary container for storing a drug, the container having a stopper movably disposed in the container for expelling the drug, an injection drive mechanism comprising a plunger for acting on the stopper and an energy source for exerting a force on the plunger to cause the plunger to act on the stopper to expel the drug, the force causing the plunger to accelerate to a velocity prior to acting on the stopper, and a damping mechanism for reducing the velocity of the plunger prior to acting on the stopper. The damping mechanism can include a dashpot or an energy absorbing material associated with the plunger. Alternatively or additionally, the damping mechanisms can include absorbing material disposed between support members of an outer casing of the injection device and the primary container.
-
公开(公告)号:US20240131263A1
公开(公告)日:2024-04-25
申请号:US18097725
申请日:2023-01-17
Applicant: AMGEN INC.
Inventor: Scott Robert Gibson , Adam B. McCullough
CPC classification number: A61M5/20 , A61M5/2033 , A61M5/31515 , A61M5/31571 , A61M5/5086 , A61M25/06
Abstract: Systems and methods for delayed delivery of a drug are disclosed. A drug delivery system may include a delivery member for insertion into a patient and a reservoir configured to receive a volume of a drug. An energy source may be activatable by the patient to actuate the reservoir to deliver the drug to the patient as a single bolus. A lockout system may be configured to have a locked state, wherein the lockout system prevents movement of the delivery member and/or activation of the energy source, and an unlocked state, wherein the lockout system permits movement of the delivery member and/or activation of the energy source. The lockout system may be configured to automatically change from the locked state to the unlocked state after a preselected time period has elapsed. An output element may generate a detectable output after the preselected time period has elapsed for notifying the patient.
-
公开(公告)号:US11305056B2
公开(公告)日:2022-04-19
申请号:US16620016
申请日:2018-07-14
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Scott Robert Gibson , Adam Livingston
Abstract: An insertion/retraction mechanism for a drug delivery device is disclosed. The insertion/retraction mechanism includes a retraction hub, an insertion hub, an insertion/retraction mechanism housing, and a dual torsion spring system. The retraction hub includes a first primary rotational stop and a second primary rotational stop extending radially inwardly from an inside surface. The insertion hub is disposed inside the retraction hub and comprises a first complementary rotational stop and a second complementary rotational stop extending radially outwardly from an outside surface. The dual torsion spring system causes the first primary rotational stop and the second primary rotational stop to selectively engage the first complementary rotational stop and the secondary rotational stop, respectively, and further causes the retraction hub to rotate relative to the insertion/retraction mechanism housing as the insertion/retraction mechanism moves between an initial position, an inserted position, and a retracted position.
-
公开(公告)号:US20220031939A1
公开(公告)日:2022-02-03
申请号:US17277599
申请日:2019-10-14
Applicant: AMGEN INC.
Inventor: Ali Nekouzadeh , Carl Conrath , Scott Robert Gibson , Basel Hasan Taha
Abstract: Methods, devices, and components are provided to reduce tissue resistive pressure during a subcutaneous drug delivery operation by increasing the size of the injection cavity by partially retracting the drug delivery member after inserting the drug delivery member to a subcutaneous position. The drug delivery devices described herein include a motor operably coupled to a drug delivery member. The motor can be selectively activated by a controller to retract the drug delivery member a predetermined distance to relieve pressure in an injection cavity in a patient. A force sensor can provide the controller with a drug delivery member insertion force. The controller can then estimate a tissue resistive pressure based on the drug delivery member insertion force and determine the predetermined distance for the partial drug delivery member retraction based on the tissue resistive pressure.
-
公开(公告)号:US20200230313A1
公开(公告)日:2020-07-23
申请号:US16620016
申请日:2018-07-03
Applicant: AMGEN INC.
Inventor: Mehran Mojarrad , Scott Robert Gibson , Adam Livingston
IPC: A61M5/142
Abstract: An insertion/retraction mechanism for a drug delivery device is disclosed. The insertion/retraction mechanism includes a retraction hub, an insertion hub, an insertion/retraction mechanism housing, and a dual torsion spring system. The retraction hub includes a first primary rotational stop and a second primary rotational stop extending radially inwardly from an inside surface. The insertion hub is disposed inside the retraction hub and comprises a first complementary rotational stop and a second complementary rotational stop extending radially outwardly from an outside surface. The dual torsion spring system causes the first primary rotational stop and the second primary rotational stop to selectively engage the first complementary rotational stop and the secondary rotational stop, respectively, and further causes the retraction hub to rotate relative to the insertion/retraction mechanism housing as the insertion/retraction mechanism moves between an initial position, an inserted position, and a retracted position.
-
-
-
-
-
-
-
-
-